Lapachone Completed Phase 2 Trials for Squamous Cell Carcinoma (SCC) / Neoplasms, Head and Neck Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00358930A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck